program145

7/55

ABSTRACT 6 AL20 2025/03/27 8:55-9:25 Room 2(FUKUOKA CONVENTION CENTER: 501 (5F)) AL21 2025/03/27 9:35-10:05 Room 2(FUKUOKA CONVENTION CENTER: 501 (5F)) AL22 2025/03/27 10:15-10:55 Room 2(FUKUOKA CONVENTION CENTER: 501 (5F)) AL23 2025/03/27 11:05-11:45 Room 2(FUKUOKA CONVENTION CENTER: 501 (5F)) (Translation service available.) (Translation service available.) (Translation service available.) (Translation service available.) Pharmaceutical health science: history, indispensability, and the development of pharmaceutical professionals for its education and practice ○Toshiyuki Kaji1 1. Tokyo Univ. of Sci. My journey in developing a fascination for the history and sciences of poisons ○Shinji Funayama1,2 1. Nihon Pharm. Univ., 2. The Jap. Soc. for the Hist. of Pharm. Discovery of ensitrelvir, a COVID-19 treatment targeting 3CL protease ○Yuki Tachibana1, Yuto Unoh1, Shota Uehara1, Haruaki Nobori1, Teruhisa Kato1 1. SHIONOGI & CO., LTD. Creation of trastuzumab deruxtecan, a novel cancer treatment drug, by innovating new-generation antibody-drug conjugate technology, DXd-ADC Toshinori Agatsuma1, ○Yuki Abe1, Hiroyuki Naito1, Takashi Nakada1, Yusuke Ogitani1 1. Daiichi Sankyo ABSTRACT ABSTRACT ABSTRACT